Vycor Medical (VYCO) Cash & Equivalents (2010 - 2026)
Vycor Medical (VYCO) reported Cash & Equivalents of $173634.0 for Q1 2026, up 184.42% year-over-year from $61049.0 in Q1 2025, and up 99.62% quarter-over-quarter from $86982.0 in Q4 2025.
Vycor Medical (VYCO) Cash & Equivalents (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Cash & Equivalents data on file, last reported at $173634.0 in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $173634.0, up 184.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $173634.0 (up 184.42% YoY), and the FY2025 annual result was $86982.0, down 17.67% from the prior year.
- Cash & Equivalents rose to $173634.0 in Q1 2026 per VYCO's latest filing, from $86982.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $173634.0 in Q1 2026 and troughed at $32570.0 in Q3 2022.
- A 5-year average of $78433.8 and a median of $64230.0 in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2026: Cash & Equivalents plunged 59.87% in 2022, then soared 184.42% in 2026.
- A 5-year view of Cash & Equivalents shows it stood at $37035.0 in 2022, then surged by 54.69% to $57291.0 in 2023, then surged by 84.41% to $105648.0 in 2024, then fell by 17.67% to $86982.0 in 2025, then surged by 99.62% to $173634.0 in 2026.
- Business Quant data shows VYCO's Cash & Equivalents at $173634.0 in Q1 2026, $86982.0 in Q4 2025, and $64230.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 173,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,634.00 |
| Dec 31, 2025 | 86,982.00 |
| Sep 30, 2025 | 64,230.00 |
| Jun 30, 2025 | 99,700.00 |
| Mar 31, 2025 | 61,049.00 |
| Dec 31, 2024 | 105,648.00 |
| Sep 30, 2024 | 157,633.00 |
| Jun 30, 2024 | 119,296.00 |
| Mar 31, 2024 | 43,857.00 |
| Dec 31, 2023 | 57,291.00 |
| Sep 30, 2023 | 69,055.00 |
| Jun 30, 2023 | 53,404.00 |
| Mar 31, 2023 | 47,805.00 |
| Dec 31, 2022 | 37,035.00 |
| Sep 30, 2022 | 32,570.00 |
| Jun 30, 2022 | 43,619.00 |
| Mar 31, 2022 | 80,567.00 |
| Dec 31, 2021 | 90,941.00 |
| Sep 30, 2021 | 78,573.00 |
| Jun 30, 2021 | 108,687.00 |